A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Key Account Manager

Field SalesConfirmed live in the last 24 hours
Full-timeGermanyNo salary listed

About the Job

Requirements

  • A university degree in a business-related field such as health or business management, or comparable educational background.
  • Certification to promote medicinal products to the national code-of-practice standard in Germany.
  • At least 7 years of sales and key account management experience in bio/pharmaceutical sales.
  • Ability to gain consistent access and develop strong, professional relationships for product promotion with healthcare providers in reference centers and the community.
  • Effective communication and influencing skills to engage with professionals at all organizational levels.
  • Strong business acumen to add value to existing healthcare structures.
  • Ability to use previous experience and insights to generate and maintain appropriate awareness and timely access to treatment.
  • Organizational and project management skills.
  • Fluency in written and spoken German and English.
  • Ability to travel regularly within the territory, approximately 80% of the time.

Responsibilities

  • Present a positive image of the company and develop awareness of its RNA interference platform with relevant healthcare professional groups.
  • Develop, own, and drive territory and account plans, including customer targeting and cycle plans, in line with marketing strategy and business operations guidance.
  • Achieve pre-launch and post-launch key performance indicators, including sales and volume targets.
  • Use advanced sales skills to ensure consistent and continuous messaging.
  • Analyze the assigned territory to identify, assess, and develop relevant centers for diagnosis and treatment.
  • Drive patient group identification, diagnosis, and referral rates through strategic intersectoral referral network management in close cooperation with other field-based functions.
  • Develop trusted relationships with a portfolio of customers to ensure market penetration, after gaining a thorough understanding of key customer needs and requirements.
  • Ensure products and services are delivered to customers in a timely manner by collaborating with internal stakeholders and external centers.
  • Establish and maintain contact with key customers and provide commercial and scientific services to ensure access at the site of care and appropriate product-administration logistics.
  • Manage and execute local meetings to drive diagnosis and treatment rates, in collaboration with the Medical Affairs team for physicians and other healthcare professionals.
  • Represent the company at local and national events and congresses.
  • Serve as the communication link between key customers and internal teams.
  • Collaborate with relevant internal staff, including Medical Affairs, Sales, Marketing, Market Access, and Business Operations, as required.
  • Lead regular local alignment meetings with other field-based functions to ensure implementation and outcomes against committed territory and account plans.
  • Report accurately and on time, and maintain the customer relationship management database.
  • Conduct all activities to the highest ethical standards in accordance with the country code of practice and local laws and regulations.
  • Travel domestically and occasionally internationally as needed.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs